Zhiping Weng
Inventions:
Title: HIGH-AFFINITY DMF5 T CELL RECEPTOR (TCR) VARIANTS. UMMS13-50; Patent 9,717,758.
-
The present invention provides amino and nucleic acid sequences for high-affinity variants of the DMF5 T-cell receptor. Further, the invention provides methods of use for the treatment and imaging of melanoma in a patient.